Paul Tudor Jones Castle Biosciences Inc Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Castle Biosciences Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 70,076 shares of CSTL stock, worth $1.44 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
70,076
Previous 49,490
41.6%
Holding current value
$1.44 Million
Previous $1.41 Million
32.32%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding CSTL
# of Institutions
210Shares Held
26.6MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$62.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$37.6 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$36.9 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$29.5 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$20.5 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $540M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...